NCT03518333View on ClinicalTrials.gov

Evaluation of the Tissue Genesis Icellator Cell Isolation System to Treat Erectile Dysfunction

NAUnknownINTERVENTIONAL
Enrollment

60

Participants

Timeline

Start Date

April 1, 2022

Primary Completion Date

March 1, 2023

Study Completion Date

September 1, 2023

Conditions
Erectile Dysfunction
Interventions
DEVICE

Injection of adipose derived cells into penis

Injection of Icellator-derived cells

Trial Locations (5)

20036

James A. Simon, Washington D.C.

21287

Johns Hopkins Kimmel Cancer Center, Baltimore

32610

University of Florida, Gainesville

77030

Scott Department of Urology, Baylor College of Medicine, Houston

92120

San Diego Sexual Medicine, San Diego

Sponsors

Lead Sponsor

Tissue Genesis
All Listed Sponsors
lead

Tissue Genesis

INDUSTRY

NCT03518333 - Evaluation of the Tissue Genesis Icellator Cell Isolation System to Treat Erectile Dysfunction | Biotech Hunter | Biotech Hunter